miR-155 assay
    1.
    发明授权
    miR-155 assay 失效
    miR-155测定

    公开(公告)号:US07700288B2

    公开(公告)日:2010-04-20

    申请号:US11352837

    申请日:2006-02-13

    IPC分类号: C12Q1/68

    摘要: The invention provides methods for diagnosing B-cell lymphoma in an animal. In particular, the invention provides methods for distinguishing an animal having diffuse large B-cell lymphoma (DLBCL) with an activated B-cell (ABC) phenotype from an animal having DLBCL with a non-activated germinal-center (GC) phenotype. The invention also provides methods for identifying compounds for treating B-cell lymphoma. The invention further provides reagents and methods for determining the amount of miR-155 in sample isolated from an animal. In this regard, the invention provides a set of oligonucleotides for determining the amount of miR-155 in sample isolated from an animal.

    摘要翻译: 本发明提供了用于诊断动物中B细胞淋巴瘤的方法。 特别地,本发明提供了从具有非活化生发中心(GC)表型的DLBCL的动物区分具有弥漫性大B细胞淋巴瘤(DLBCL)的动物与活化的B细胞(ABC)表型的方法。 本发明还提供鉴定用于治疗B细胞淋巴瘤的化合物的方法。 本发明还提供用于测定从动物分离的样品中miR-155的量的试剂和方法。 在这方面,本发明提供了一组用于确定从动物分离的样品中miR-155的量的寡核苷酸。